Company Filing History:
2 out of 676 
2 out of 485 
Years Active: 2006-2008
Title: Mia Hijazi: Innovator in Cell Growth Regulation
Introduction
Mia Hijazi is a prominent inventor based in Washington, DC. She has made significant contributions to the field of biotechnology, particularly in the area of cell growth regulation. With a total of 2 patents, her work has the potential to impact therapeutic methods and diagnostic techniques.
Latest Patents
Mia's latest patents include the development of a Heregulin-like factor, which relates to a novel HLF protein that is a member of the heregulin family. This invention provides isolated nucleic acid molecules encoding the human HLF protein, along with HLF polypeptides, vectors, host cells, and recombinant methods for production. Additionally, her patent outlines screening methods for identifying agonists and antagonists of HLF activity, as well as diagnostic methods for detecting disorders related to cell growth regulation and therapeutic methods for treating such disorders. Another significant patent focuses on Heregulin-like factor antibodies, which shares similar features and applications as her first patent.
Career Highlights
Mia has worked with notable organizations such as Human Genome Sciences, Inc. and Georgetown University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Mia has collaborated with esteemed colleagues, including Paul E. Young and Steven M. Ruben. Their combined expertise has further advanced the research and development of innovative solutions in biotechnology.
Conclusion
Mia Hijazi's contributions to the field of biotechnology, particularly in cell growth regulation, highlight her role as an influential inventor. Her patents and collaborations reflect her commitment to advancing scientific knowledge and improving therapeutic methods.